$ARCT News Article - Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR(TM) mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study
https://marketwirenews.com/news-releases/arct...95529.html